2RGP
Structure of EGFR in complex with hydrazone, a potent dual inhibitor
Summary for 2RGP
Entry DOI | 10.2210/pdb2rgp/pdb |
Descriptor | Epidermal growth factor receptor, PHOSPHATE ION, N-[1-(3-fluorobenzyl)-1H-indazol-5-yl]-5-[(piperidin-1-ylamino)methyl]pyrimidine-4,6-diamine, ... (4 entities in total) |
Functional Keywords | kinase domain, alternative splicing, anti-oncogene, atp-binding, cell cycle, disease mutation, glycoprotein, membrane, nucleotide-binding, phosphoprotein, polymorphism, receptor, secreted, transferase, transmembrane, tyrosine-protein kinase, ubl conjugation |
Biological source | Homo sapiens (Human) |
Cellular location | Cell membrane; Single-pass type I membrane protein. Isoform 2: Secreted: P00533 |
Total number of polymer chains | 1 |
Total formula weight | 36707.27 |
Authors | Abad, M.C. (deposition date: 2007-10-04, release date: 2008-08-26, Last modification date: 2023-08-30) |
Primary citation | Xu, G.,Abad, M.C.,Connolly, P.J.,Neeper, M.P.,Struble, G.T.,Springer, B.A.,Emanuel, S.L.,Pandey, N.,Gruninger, R.H.,Adams, M.,Moreno-Mazza, S.,Fuentes-Pesquera, A.R.,Middleton, S.A. 4-Amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitors. Bioorg.Med.Chem.Lett., 18:4615-4619, 2008 Cited by PubMed: 18653333DOI: 10.1016/j.bmcl.2008.07.020 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report